Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inh (Q43848863)
Jump to navigation
Jump to search
scientific article published in January 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inh |
scientific article published in January 2002 |
Statements
1 reference
Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inh (English)
1 reference
Steffen Frese
1 reference
Thomas Brunner
1 reference
Mathias Gugger
1 reference
Aima Uduehi
1 reference
Ralph A Schmid
1 reference
1 January 2002
1 reference
1 reference
Identifiers
1 reference